Pharmaceutical Holding Aims for 18.9B EGP Revenue
The holding company for pharmaceuticals aims to achieve revenues of 18.9 billion Egyptian pounds and a net profit of 3.6 billion Egyptian pounds during the years 2026-2027, through expanding export operations and enhancing production capabilities.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)